Keywords: pfizer, antifungal, vfend, cleared, usa, serious, infections

Pfizer's antifungal Vfend cleared in USA for serious infections

Article | 03 June 2002

Print This

Pfizer gained approval for a new product in its antifungal franchiseVfend (voriconazole) in the USA on May 28, and said the ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in